Marcio Natividade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcio Natividade has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Erika Aragão
Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brasil
6 shared publications - Marcos Pereira
Universidade Federal da Bahia
6 shared publications - Samilly Silva Miranda
Collective Health Institute Federal University of Bahia Salvador Bahia Brazil
6 shared publications - Joilda Silva Nery
Universidade Federal da Bahia, Brasil
5 shared publications - Juracy Bertoldo Junior
Centro de Integração de Dados e Conhecimento em Saúde (CIDACS), Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, R. Mundo, 121 - sala 315 - Trobogy, Salvador, 41745-715, Brazil, 55 7131762357
3 shared publications - Bruna Rebouças da Fonseca
Universidade Federal da Bahia (UFBA), Brazil
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-9
Comparative Analysis of the Average Recommendation Time for the Incorporation of Biological Drugs for Cancer and Rheumatoid Arthritis
To compare the average time between the registration of a biological drug and its recommendation for incorporation for rheumatoid arthritis (RA) and cancer (CA) at national and international levels. This retrospective, comparative study analyzed the time taken to incorporate biological drugs recommended by National Commission for the Incorporation of Technologies (CONITEC) in the Brazilian Unified Health System(SUS) for RA and CA from January 1, 2012, to March 28, 2024. The incorporation time in Brazil was compared to that of regulatory bodies in England and Australia for the same treatments. Kaplan-Meier curves and the Log rank test were used to estimate time differences between countries. In Brazil, biological drugs for RA took an average of 2,019 days from the National Health Surveillance Agency (ANVISA) approval to CONITEC’s incorporation recommendation. In England, the averages were 1,242 days for RA and 1,683 for CA, while in Australia, it was 744 days for RA and 1,315 for CA. Australia incorporated drugs faster than both England and Brazil. The lengthy process in Brazil for incorporating biological technologies for RA and CA may hinder access, delaying treatment for many patients. This barrier is particularly significant for low-income individuals who rely exclusively on the SUS.
- 1 April 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-9
Open AccessComparative Analysis of the Average Recommendation Time for the Incorporation of Biological Drugs for Cancer and Rheumatoid Arthritis
To compare the average time between the registration of a biological drug and its recommendation for incorporation for rheumatoid arthritis (RA) and cancer (CA) at national and international levels. This retrospective, comparative study analyzed the time taken to incorporate biological drugs recommended by National Commission for the Incorporation of Technologies (CONITEC) in the Brazilian Unified Health System(SUS) for RA and CA from January 1, 2012, to March 28, 2024. The incorporation time in Brazil was compared to that of regulatory bodies in England and Australia for the same treatments. Kaplan-Meier curves and the Log rank test were used to estimate time differences between countries. In Brazil, biological drugs for RA took an average of 2,019 days from the National Health Surveillance Agency (ANVISA) approval to CONITEC’s incorporation recommendation. In England, the averages were 1,242 days for RA and 1,683 for CA, while in Australia, it was 744 days for RA and 1,315 for CA. Australia incorporated drugs faster than both England and Brazil. The lengthy process in Brazil for incorporating biological technologies for RA and CA may hinder access, delaying treatment for many patients. This barrier is particularly significant for low-income individuals who rely exclusively on the SUS.
- Open Access
- 30 July 2025
- Published by Instituto de Saude da Secretaria de Estado da Saude de Sao Paulo in Boletim do Instituto de Saúde - BIS
- Vol. 26 (1) , 49-55
Descrição do perfil e da trajetória acadêmica dos concorrentes nos editais paulistas do Programa de Pesquisa para o SUS (PPSUS) 2009-2016
Este artigo buscou analisar o perfil do pesquisador que buscou recursos para pesquisas por meio dos editais PPSUS. Utilizou-se dados do Sistema de Informação de Ciência e Tecnologia em Saúde (SISCT) com todas as informações dos editais do PPSUS entre os anos de 2009 e 2018, para obter informações dos currículos dos pesquisadores, cujos dados foram estruturados e organizados de forma longitudinal. Em seguida, foi estudado o perfil do pesquisador que concorreu nos editais paulistas do PPSUS de 2009, 2012, 2013 e 2016, utilizando um conjunto de dados da Plataforma Lattes e do Ministério da Saúde. O banco de dados do Lattes foi conectado com o banco de dados do PPSUS pela chave id Lattes, por meio de uma vinculação determinística. Um segundo vínculo, probabilístico, foi realizado com o banco de dados Pesquisa Saúde, do Ministério da Saúde. Dessa forma, comparou-se a tendência de artigos publicados de um grupo tratado (financiado pelo PPSUS) com um grupo controle (não financiado pelo PPSUS), no período observado. Os resultados, a partir de uma avaliação estatística controlada, sugerem uma associação entre receber financiamento do PPSUS por jovens pesquisadores e um aumento no volume total de publicações acadêmicas dos beneficiados em São Paulo.
- 30 July 2025
- Published by Instituto de Saude da Secretaria de Estado da Saude de Sao Paulo in Boletim do Instituto de Saúde - BIS
- Vol. 26 (1) , 49-55
Open AccessDescrição do perfil e da trajetória acadêmica dos concorrentes nos editais paulistas do Programa de Pesquisa para o SUS (PPSUS) 2009-2016
Este artigo buscou analisar o perfil do pesquisador que buscou recursos para pesquisas por meio dos editais PPSUS. Utilizou-se dados do Sistema de Informação de Ciência e Tecnologia em Saúde (SISCT) com todas as informações dos editais do PPSUS entre os anos de 2009 e 2018, para obter informações dos currículos dos pesquisadores, cujos dados foram estruturados e organizados de forma longitudinal. Em seguida, foi estudado o perfil do pesquisador que concorreu nos editais paulistas do PPSUS de 2009, 2012, 2013 e 2016, utilizando um conjunto de dados da Plataforma Lattes e do Ministério da Saúde. O banco de dados do Lattes foi conectado com o banco de dados do PPSUS pela chave id Lattes, por meio de uma vinculação determinística. Um segundo vínculo, probabilístico, foi realizado com o banco de dados Pesquisa Saúde, do Ministério da Saúde. Dessa forma, comparou-se a tendência de artigos publicados de um grupo tratado (financiado pelo PPSUS) com um grupo controle (não financiado pelo PPSUS), no período observado. Os resultados, a partir de uma avaliação estatística controlada, sugerem uma associação entre receber financiamento do PPSUS por jovens pesquisadores e um aumento no volume total de publicações acadêmicas dos beneficiados em São Paulo.
- 14 February 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (2) , e70114
Geographic and Temporal Patterns in Biologic Prescriptions for Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: An Ecological Study
Purpose: To analyze the geographic and temporal patterns of biologic prescriptions for inflammatory bowel disease (IBD) in Brazil's public national unified health system (SUS).Methods: This ecological study used data from patients with IBD in the SUS Outpatient Information System between 2008 and 2022. Prais‐Winsten regression was used to estimate the trends in prescription rate of biologics. For geographic analysis, average prescription rate of biologics was calculated by state for three periods: 2008–2012, 2013–2017, and 2018–2022. Global Moran's index (GMI) and local indicators of spatial autocorrelation (LISA) were used to assess spatial autocorrelation and identify spatial clusters of biologic prescriptions, respectively.Results: The prescription rate of biologics increased from 3.0% to 16.7%. Infliximab was the most prescribed drug from 2008 to 2012 (3.0%–4.2%), and adalimumab was the most widely prescribed drug from 2013 to 2022 (4.3%–9.1%). Higher prescription rates of biologics were observed in patients with Crohn's disease than in those with ulcerative colitis (40.5% vs. 3.2%). Biologics were primarily prescribed in the Southeast and South; however, the central‐western and northern regions showed greater changes in prescription rates over time. There were increased clusters of high biologic prescriptions across the three evaluated periods.Conclusions: The increase in biologic prescriptions over time may be attributed to their enhanced efficacy in inducing and maintaining IBD remission. Biologic prescriptions in Brazil are experiencing temporal and geographical changes, indicating that disparities in drug prescriptions may decrease with universal, equitable healthcare access, despite administrative challenges in obtaining these medications through SUS.
- 14 February 2025
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 34 (2) , e70114
Geographic and Temporal Patterns in Biologic Prescriptions for Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: An Ecological Study
Purpose: To analyze the geographic and temporal patterns of biologic prescriptions for inflammatory bowel disease (IBD) in Brazil's public national unified health system (SUS).Methods: This ecological study used data from patients with IBD in the SUS Outpatient Information System between 2008 and 2022. Prais‐Winsten regression was used to estimate the trends in prescription rate of biologics. For geographic analysis, average prescription rate of biologics was calculated by state for three periods: 2008–2012, 2013–2017, and 2018–2022. Global Moran's index (GMI) and local indicators of spatial autocorrelation (LISA) were used to assess spatial autocorrelation and identify spatial clusters of biologic prescriptions, respectively.Results: The prescription rate of biologics increased from 3.0% to 16.7%. Infliximab was the most prescribed drug from 2008 to 2012 (3.0%–4.2%), and adalimumab was the most widely prescribed drug from 2013 to 2022 (4.3%–9.1%). Higher prescription rates of biologics were observed in patients with Crohn's disease than in those with ulcerative colitis (40.5% vs. 3.2%). Biologics were primarily prescribed in the Southeast and South; however, the central‐western and northern regions showed greater changes in prescription rates over time. There were increased clusters of high biologic prescriptions across the three evaluated periods.Conclusions: The increase in biologic prescriptions over time may be attributed to their enhanced efficacy in inducing and maintaining IBD remission. Biologic prescriptions in Brazil are experiencing temporal and geographical changes, indicating that disparities in drug prescriptions may decrease with universal, equitable healthcare access, despite administrative challenges in obtaining these medications through SUS.
- Open Access
- 21 February 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 58 (1) , 21
Estrutura e processo na atenção primária à saúde das crianças e distribuição espacial da mortalidade infantil
OBJECTIVE: To identify the spatial patterns of the quality of the structure of primary health care services and the teams’ work process and their effects on infant mortality in Brazil. METHODS: An ecological study of spatial aggregates, using the 5,570 municipalities in Brazil as the unit of analysis. Secondary databases from the Programa Nacional de Melhoria do Acesso e Qualidade da Atenção Básica (PMAQ-AB – National Program for Improving Access and Quality of Primary Care), the Mortality Information System (SIM), and the Live Birth Information System (SINASC) were used. In 2018, the infant mortality rate was the outcome of the study, and the exposure variables were the proportion of basic health units (BHU) with adequate structure and work processes. Global and local Moran’s indices were used to evaluate the degree of dependence and spatial autocorrelation. Spatial linear regression was used for data analysis. RESULTS: In 2018, in Brazil, the infant mortality rate was 12.4/1,000 live births, ranging from 10.6/1,000 and 11.2/1,000 in the South and Southeast, respectively, to 14.1/1,000 and 14.5/1,000 in the Northeast and North regions, respectively. The proportion of teams with an adequate work process (β = −3.13) and the proportion of basic health units with an adequate structure (β = −0.34) were associated with a reduction in the infant mortality rate. Spatial autocorrelation was observed between smoothed mean infant mortality rates and indicators of the structure of primary health care services and the team’s work process, with higher values in the North and Northeast of Brazil. CONCLUSIONS: There is a relationship between the structure of primary health care services and the teams’ work process with the infant mortality rate. In this sense, investment in the qualification of health care within the scope of primary health care can have an impact on reducing the infant mortality rate and improving child health care.
- 21 February 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Saúde Pública
- Vol. 58 (1) , 21
Open AccessEstrutura e processo na atenção primária à saúde das crianças e distribuição espacial da mortalidade infantil
OBJECTIVE: To identify the spatial patterns of the quality of the structure of primary health care services and the teams’ work process and their effects on infant mortality in Brazil. METHODS: An ecological study of spatial aggregates, using the 5,570 municipalities in Brazil as the unit of analysis. Secondary databases from the Programa Nacional de Melhoria do Acesso e Qualidade da Atenção Básica (PMAQ-AB – National Program for Improving Access and Quality of Primary Care), the Mortality Information System (SIM), and the Live Birth Information System (SINASC) were used. In 2018, the infant mortality rate was the outcome of the study, and the exposure variables were the proportion of basic health units (BHU) with adequate structure and work processes. Global and local Moran’s indices were used to evaluate the degree of dependence and spatial autocorrelation. Spatial linear regression was used for data analysis. RESULTS: In 2018, in Brazil, the infant mortality rate was 12.4/1,000 live births, ranging from 10.6/1,000 and 11.2/1,000 in the South and Southeast, respectively, to 14.1/1,000 and 14.5/1,000 in the Northeast and North regions, respectively. The proportion of teams with an adequate work process (β = −3.13) and the proportion of basic health units with an adequate structure (β = −0.34) were associated with a reduction in the infant mortality rate. Spatial autocorrelation was observed between smoothed mean infant mortality rates and indicators of the structure of primary health care services and the team’s work process, with higher values in the North and Northeast of Brazil. CONCLUSIONS: There is a relationship between the structure of primary health care services and the teams’ work process with the infant mortality rate. In this sense, investment in the qualification of health care within the scope of primary health care can have an impact on reducing the infant mortality rate and improving child health care.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 142 (6) , e2023279
Impact of the improvement of living conditions on tuberculosis mortality in Brazil: an ecological study
The risk of death due to tuberculosis (TB) in Brazil is high and strongly related to living conditions (LC). However, epidemiological studies investigating changes in LC and their impact on TB are lacking.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 142 (6) , e2023279
Open AccessImpact of the improvement of living conditions on tuberculosis mortality in Brazil: an ecological study
The risk of death due to tuberculosis (TB) in Brazil is high and strongly related to living conditions (LC). However, epidemiological studies investigating changes in LC and their impact on TB are lacking.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (3) , e04882023
Associação entre iniquidades raciais e condição de saúde bucal: revisão sistemática
Resumo O objetivo deste estudo é investigar a associação entre iniquidades raciais e condição de saúde bucal. Trata-se de revisão sistemática com protocolo cadastrado na plataforma prospero (CRD42021228417), com buscas realizadas em bases de dados eletrônicas e na literatura cinzenta. Identificou-se 3.028 publicações e após aplicação dos critérios de elegibilidade e análise do risco de vieses, 18 estudos foram selecionados. Os resultados indicam que indivíduos de raça/cor da pele preta/parda apresentam condições de saúde bucal desfavorável, representada principalmente pela autoavaliação de saúde bucal, perda dentária, cárie e periodontite. Os resultados evidenciaram iniquidades raciais em saúde bucal em diferentes países, para todos os indicadores analisados, com maior vulnerabilidade da população negra.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (3) , e04882023
Open AccessAssociação entre iniquidades raciais e condição de saúde bucal: revisão sistemática
Resumo O objetivo deste estudo é investigar a associação entre iniquidades raciais e condição de saúde bucal. Trata-se de revisão sistemática com protocolo cadastrado na plataforma prospero (CRD42021228417), com buscas realizadas em bases de dados eletrônicas e na literatura cinzenta. Identificou-se 3.028 publicações e após aplicação dos critérios de elegibilidade e análise do risco de vieses, 18 estudos foram selecionados. Os resultados indicam que indivíduos de raça/cor da pele preta/parda apresentam condições de saúde bucal desfavorável, representada principalmente pela autoavaliação de saúde bucal, perda dentária, cárie e periodontite. Os resultados evidenciaram iniquidades raciais em saúde bucal em diferentes países, para todos os indicadores analisados, com maior vulnerabilidade da população negra.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (3) , e04882023
Association between racial iniquities and oral health status: a systematic review
The present study aimed to investigate the association between racial iniquities and oral health status. This is a systematic review with a protocol registered on the Prospero Platform (CRD42021228417), with searches carried out in electronic databases and in gray literature. Our study identified 3,028 publications. After applying the eligibility criteria and risk of bias analysis, 18 studies were selected. The results indicate that individuals of black/brown race/skin color have unfavorable oral health conditions, mainly represented by self-rated oral health, tooth loss, caries, and periodontitis. The results showed racial iniquities in oral health in different countries, for all analyzed indicators, with a greater vulnerability of the black population.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 29 (3) , e04882023
Open AccessAssociation between racial iniquities and oral health status: a systematic review
The present study aimed to investigate the association between racial iniquities and oral health status. This is a systematic review with a protocol registered on the Prospero Platform (CRD42021228417), with searches carried out in electronic databases and in gray literature. Our study identified 3,028 publications. After applying the eligibility criteria and risk of bias analysis, 18 studies were selected. The results indicate that individuals of black/brown race/skin color have unfavorable oral health conditions, mainly represented by self-rated oral health, tooth loss, caries, and periodontitis. The results showed racial iniquities in oral health in different countries, for all analyzed indicators, with a greater vulnerability of the black population.
- Open Access
- 7 June 2023
- Published by Elsevier in Vaccine: X
- Vol. 14, 100323
Evolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort
- 7 June 2023
- Published by Elsevier in Vaccine: X
- Vol. 14, 100323
Open AccessEvolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
The geographical access of users with diabetes and hypertension to the 'there's a people's pharmacy here' programme (atfp), brazil
Introduction: Access to medication constitutes one of the most important socio-economic challenges to treatment continuity. In Brazil, one initiative to expand access to the medication available through primary healthcare is the ‘There’s a People’s Pharmacy Here’ Programme _(Programa...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessThe geographical access of users with diabetes and hypertension to the 'there's a people's pharmacy here' programme (atfp), brazil
Introduction: Access to medication constitutes one of the most important socio-economic challenges to treatment continuity. In Brazil, one initiative to expand access to the medication available through primary healthcare is the ‘There’s a People’s Pharmacy Here’ Programme _(Programa...
- Open Access
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Effect of the 'there's a people's pharmacy here' programme on hypertension and diabetes-related mortality
Background and objective: Information about the real prevalence of non-communicable diseases (NCDs) in Brazil, and their rate of treatment and control, remains scarce. Despite the evolution of technologies for medical treatment, some sections of the population do not adhere to it. This study...
- 26 April 2023
- Published by European Publishing in Population Medicine
- Vol. 5 (Supplement)
Open AccessEffect of the 'there's a people's pharmacy here' programme on hypertension and diabetes-related mortality
Background and objective: Information about the real prevalence of non-communicable diseases (NCDs) in Brazil, and their rate of treatment and control, remains scarce. Despite the evolution of technologies for medical treatment, some sections of the population do not adhere to it. This study...